Funding for this research was provided by:
Vetenskapsrådet (K2011-52X-21737-01-3, 2018- 654 02562)
Cancerfonden (2016/365, 2017/664)
Fru Berta Kamprad Foundation (N/A)
Skåne University Hospital donation funds (N/A)
Governmental funding of clinical research within the national health services, ALF (N/A)
Viveca Jeppsson (N/A)
Text and Data Mining valid from 2019-06-07
Received: 4 April 2019
Accepted: 13 May 2019
First Online: 7 June 2019
Ethics approval and consent to participate
: Tumor samples were collected with informed consent according to Protocol H15642/2008 approved by the Lund University Regional Ethics Board, Sweden. Patient plasma samples were from a population-based trial cohort (“MRI study”) encompassing patients referred to the Neurosurgery Department at Lund University Hospital, Lund, with a suspicion of an intracranial tumor. The study was carried out according to the ICH/GCP guidelines and in agreement with the Helsinki declaration, and was approved by the local ethics committee, Lund University (Dnr.2011/814, and 2012/188). Animal studies were approved by the ethical committee for animal research in Malmö/Lund (ethical permit M144–14 and M145–14) and were performed in accordance with the European Union animal rights and ethics directives.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.